June 2, 2021
THE FRESH SQUEEZE
Juiced by:
Did someone forward this to you? Subscribe by clicking on the button below:
BLOOMBITES
Happy June! In another strong signal of our local software ecosystem, public analytics software maker Alteryx is launching a $50M venture fund. The deep analytics roots and talent in OC is producing a number of early stage startups and now local capital will help fund them. This is a great win for the ecosystem.

Another win is an impending exit from Acorns with a planned $2.2B reverse merger to go public with SPAC Pioneer Merger Corp. Acorns had a massive Q1 and is riding the momentum. These are the kinds of milestones that really lift an ecosystem for decades.

Keep it up OC!

Cheers,
How are we doing?
Please share your feedback with us.
PODCAST & WEBINAR
Jeff Martin is CEO and Founder of Collective Genius, which he started 15 years ago to build high growth companies with talent recruiting, leadership team planning and tools.
JOBS SPOTLIGHT
ONLINE EVENTS & DEADLINES
Cox Business Cloud Streams Virtual Webinar

Fresh Squeezed Tech Live: Cybersecurity Night

2021 Amazon Web Services Imagine Grant
FUNDINGS
Acorns, financial-tech company, to go public in $2B SPAC Deal with Pioneer Merger Corp

Alteryx, analytics automation company, introduces $50M Strategic Venture Fund

Sambazon, fresh juices and smoothies, $45M with NextWorld Evergreen

Docbot, image-assisted AI for gastrointestinal care, $4M Series A with Khosla Ventures, Bold Capital Partners, Collaborative Fund

iLife, insurance automation, $4M Series Seed with Foundation Capital, AME Cloud Ventures, Cherubic

Prodoscore, employee productivity tech, $3M Series A with Troy Carter, SNK Capital Partners
ACQUISITIONS
Catena Media acquired Lineups.com, an online US sports betting site, for $39.6M.

Clinigence, a health information technology company, acquired ProCare Health, a management services organization, for an undisclosed amount.

Stewart acquired Cloudvirga, a fintech company powering digital mortgages, for an undisclosed amount.

Compass Therapeutics acquired Trigr Therapeutics for clinical-phase bispecific antibody, for an undisclosed amount.
Do you like the content in this week's newsletter? Please share to your favorite network:
ZEST OF THE MONTH
Interested in sponsoring this email?
Please contact zesty@freshsqueezedtech.com for more information and sponsorship opportunities.
Have a tip or scoop? 
Feel free to tell us about it: zesty@freshsqueezedtech.com

How are we doing?
Please share your feedback with us.

Follow us for the latest tech news!